Devices
Anumana Gets Breakthrough on ECG-AI Algorithm
FDA has granted Anumana a breakthrough device designation for its ECG-AI algorithm, which is designed to aid the early identification of cardiac amyloidosis, a life-threatening, rare, underdiagnosed cause of heart failure. “The use of AI algorithms to identify subtle signals in [electrocardiograms] ECGs that are imperceptible to humans